Complementarity of electrophoretic, mass spectrometric, and gene sequencing techniques for the diagnosis and characterization of congenital disorders of glycosylation

Archive ouverte

Bruneel, Arnaud | Cholet, Sophie | Drouin-Garraud, Valérie | Jacquemont, Marie-Line | Cano, Aline | Mégarbané, André | Ruel, Coralie | Cheillan, David | Dupré, Thierry | Vuillaumier-Barrot, Sandrine | Séta, Nathalie | Fenaille, François

Edité par CCSD ; Wiley-VCH Verlag -

International audience. Congenital disorders of glycosylation (CDG) are rare autosomal genetic diseases affecting the glycosylation of proteins and lipids. Since CDG-related clinical symptoms are classically extremely variable and nonspecific, a combination of electrophoretic, mass spectrometric, and gene sequencing techniques is often mandatory for obtaining a definitive CDG diagnosis, as well as identifying causative gene mutations and deciphering the underlying biochemical mechanisms. Here, we illustrate the potential of integrating data from capillary electrophoresis of transferrin, two-dimensional electrophoresis of N- and O-glycoproteins, mass spectrometry analyses of total serum N-linked glycans and mucin core1 O-glycosylated apolipoprotein C-III for the determination of various culprit CDG gene mutations. "Step-by-step" diagnosis pathways of four particular and new CDG cases, including MGAT2-CDG, ATP6V0A2-CDG, SLC35A2-CDG, and SLC35A3-CDG, are described as illustrative examples.

Suggestions

Du même auteur

CCDC115-CDG: A new rare and misleading inherited cause of liver disease

Archive ouverte | Girard, Muriel | CCSD

International audience. Congenital disorders of glycosylation (CDG) linked to defects in Golgi apparatus homeostasis constitute an increasing part of these rare inherited diseases. Among them, COG-CDG, ATP6V0A2-CDG,...

A mutation in SLC37A4 causes a dominantly inherited congenital disorder of glycosylation characterized by liver dysfunction

Archive ouverte | Ng, Bobby | CCSD

International audience. SLC37A4 encodes an endoplasmic reticulum (ER)-localized multitransmembrane protein required for transporting glucose-6-phosphate (Glc-6P) into the ER. Once transported into the ER, Glc-6P is ...

Efficacy of oral manganese and D-galactose therapy in a patient bearing a novel TMEM165 variant

Archive ouverte | Durin, Zoé | CCSD

International audience. TMEM165-CDG has first been reported in 2012 and manganese supplementation was shown highly efficient in rescuing glycosylation in isogenic KO cells. The unreported homozygous missense c.928G&...

Chargement des enrichissements...